Abstracts (poster) - Wissenschaft Online
Abstracts (poster) - Wissenschaft Online
Abstracts (poster) - Wissenschaft Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Sonja Röhrs, Julia Romani, Wilhelm Dirks, Hans G. Drexler, Hilmar Quentmeier<br />
Methylation profiles of tumour suppressor genes in Hodgkin<br />
and non-Hodgkin lymphoma cell lines<br />
Epigenetic inactivation of tumour suppressor genes (TSGs) by promoter CpG island<br />
methylation is frequently observed in neoplasia. It is generally agreed, that CpG island<br />
hypermethylation profiles are specific for different tumour types. Therefore, the<br />
methylation patterns of TSGs might prove useful in cancer diagnosis and indicative of<br />
cellular drug responses. Here, we set out to elucidate whether the methylation profile of<br />
TSGs would allow the classification of diverse lymphoma entities. We analysed the<br />
methylation status of 24 different TSGs in combination with copy number changes.<br />
Thirty-nine lymphoma cell lines were tested, representing Hodgkin lymphoma plus five<br />
distinct subtypes of non-Hodgkin lymphoma. For this approach we used a methylationspecific<br />
MLPA (Multiplex Ligation-dependent Probe Amplification) assay. Using<br />
quantitative real time PCR, we confirmed transcriptional silencing of hypermethylated<br />
TSGs, discovered by MLPA. We identified a group of TSGs, generally methylated or<br />
deleted in all analysed lymphoma cell lines (e.g. CDH13, IGSF4, RARbeta). We also<br />
found several TSGs, that were preferentially methylated in specific lymphoma subtypes<br />
(e.g. CD44, CHFR, RASSF1A). Our results support methylation studies (e.g. for RARbeta<br />
and RASSF1A) performed on primary lymphoma patient material 1,2 , confirming the<br />
applicability of cell lines as model systems. This screening method, thus revealed<br />
potential novel epigenetic markers for Hodgkin and non-Hodgkin lymphoma.<br />
Literature<br />
1 Murray P. G., Qiu G. H., Fu L. et al. (2004) Frequent epigenetic inactivation of the<br />
RASSF1A tumor suppressor gene in Hodgkin´s lymphoma. Oncogene 23 (6): 1326-31.<br />
2 Shi H., Guo J., Duff D. J., Rahmatpanah F. et al. (2007) Discovery of novel epigenetic<br />
markers in non-Hodgkin´s lymphoma. Carcinogenesis 28, 1: 60-70.<br />
contact:<br />
Dr. Sonja Röhrs<br />
DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH<br />
Department of human and animal cell lines<br />
sro07@dsmz.de<br />
Inhoffenstr. 7B<br />
38124 Braunschweig (Germany)